Clinical Trials Browser

Completed × Cannabidiol × Clear all

NCT05388058 2026-01-16

Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Phase 2 Completed

40 enrolled 15 charts

OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

NCT03948074 2025-09-10

CAFCARS

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

NCT04754399 2025-05-09

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

Phase 2 Completed

40 enrolled 10 charts

Breast Neoplasms, Arthralgia

NCT04585841 2023-07-24

The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy

Phase 1 Completed

Appetitive Behavior, Cachexia, Marijuana Abuse, Dysgeusia, Nausea, Neoplasms, Vomiting

NCT04447846 2023-05-25

Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome

Phase 2 Completed

11 enrolled 25 charts

Sturge-Weber Syndrome, Cognitive Dysfunction

NCT02544750 2022-07-14

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Phase 3 Completed

199 enrolled 14 charts

Seizures, Tuberous Sclerosis

NCT02332655 2022-03-02

Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Phase 1/2 Completed

5 enrolled 8 charts

Drug Resistant Epilepsy, Sturge-Weber Syndrome